Title |
A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections
|
---|---|
Published in |
BMC Infectious Diseases, November 2012
|
DOI | 10.1186/1471-2334-12-297 |
Pubmed ID | |
Authors |
Peter Matthews, Marc Alpert, Galia Rahav, Denise Rill, Edward Zito, David Gardiner, Ron Pedersen, Timothy Babinchak, Paul C McGovern, , for the Tigecycline 900 cSSSI Study Group |
Abstract |
Complicated skin and skin structure infections (cSSSIs) frequently result in hospitalization with significant morbidity and mortality. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 74 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 1% |
Ethiopia | 1 | 1% |
Greece | 1 | 1% |
Switzerland | 1 | 1% |
Unknown | 70 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 13 | 18% |
Student > Ph. D. Student | 7 | 9% |
Professor > Associate Professor | 6 | 8% |
Student > Bachelor | 5 | 7% |
Professor | 4 | 5% |
Other | 21 | 28% |
Unknown | 18 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 31 | 42% |
Agricultural and Biological Sciences | 7 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 5% |
Immunology and Microbiology | 3 | 4% |
Biochemistry, Genetics and Molecular Biology | 2 | 3% |
Other | 4 | 5% |
Unknown | 23 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 September 2019.
All research outputs
#7,175,982
of 22,685,926 outputs
Outputs from BMC Infectious Diseases
#2,364
of 7,643 outputs
Outputs of similar age
#55,362
of 179,649 outputs
Outputs of similar age from BMC Infectious Diseases
#26
of 151 outputs
Altmetric has tracked 22,685,926 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 7,643 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 179,649 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 151 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.